Arcus Biosciences to Participate in Two Upcoming Investor Conferences

On February 28, 2024 Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, reported that its management team will participate in the following upcoming investor conferences in March (Press release, Arcus Biosciences, FEB 28, 2024, View Source [SID1234640626]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leerink Global Biopharma Conference 2024
Date: Monday, March 11th, 2024 at 4:00 p.m. ET
Location: Miami Beach, FL
Format: Fireside Chat

Barclays 26th Annual Global Healthcare Conference
Date: Tuesday, March 12th, 2024 at 2:35 p.m. ET
Location: Miami Beach, FL
Format: Fireside Chat

Live webcasts of the fireside chats and panel will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following each live event.